Search for: "TAKEDA PHARMACEUTICALS INTERNATIONAL, INC." Results 1 - 20 of 41
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals International AG, and Takeda Pharmaceuticals America, Inc.) sued to enjoin Defendants from marketing generic versions on the basis of inducing and/or contributorily infringing various patents, including U.S. [read post]
26 Apr 2021, 7:42 am by Race to the Bottom
Moderna also entered into deals with Catalent Inc. and Baxter International Inc. to help fill vaccine vials, and Takeda will use an existing facility in Japan to manufacture, import, and distribute vaccines. [read post]
2 Apr 2020, 6:30 am by Andrew Hamm
Takeda Pharmaceutical Co. v. [read post]
1 Dec 2017, 11:35 am by Nate Nead
Bard in Q2 2017 helped increase the value of deals.[27] Takeda Pharmaceutical Company acquired ARIAD Pharmaceuticals Inc for $5.2 billion to expand its oncology business. [read post]
3 May 2016, 9:00 pm by Dennis Crouch
Guest Post By: Paul Dietze and Mini Kapoor, Haynes and Boone, LLP[1]  On March 18, 2016, the Federal Circuit held that Mylan Pharmaceuticals, Inc. [read post]
28 Jul 2015, 11:52 am by Schachtman
Merrell Dow Pharmaceuticals Inc., 43 F.3d 1311, 1320 (9th Cir.), cert. denied 516 U.S. 869 (1995) [Daubert II]. [read post]
3 Sep 2014, 9:00 am by Maureen Johnston
Takeda Pharmaceutical Company Limited 13-1236Issue: Whether the “freely given” standard for the amendment of pleading embodied in Federal Rule of Civil Procedure 15(a), and espoused in Foman v. [read post]
1 Sep 2014, 7:04 am
. * Letter from AmeriKat: Judge Koh declares Takeda takes it too far with Mylan Dexilant declaration: The AmeriKat is back with a case review of Takeda Pharmaceutical Co., Ltd. et al v Mylan Inc. et al (here). [read post]
3 May 2014, 8:56 am by Schachtman
Merrell Dow Pharmaceuticals, Inc., 89 F.3d 594, 596-98 (9th Cir. 1996) (affirming exclusion of Dr. [read post]
15 May 2013, 4:45 am
Bankosky worked for Takeda Pharmaceuticals International, Inc., first as a director of Global Licensing and Business Development and then as a senior director. [read post]
5 Jun 2012, 12:10 pm by David Smyth
In that case, Bankosky had been a director in the business development group at Takeda Pharmaceuticals International, Inc. [read post]
17 Feb 2012, 2:00 am by Stephanie Figueroa
NetApp, Inc., where the issue was whether supplemental documents should be produced to comply with post-trial determination pursuant to DGCL Section 220 that books and records must be provided. 2) DealBook: Kodak Can Remove Name From Oscar Venue, Judge Rules – This post shares how lawyers for Eastman Kodak won bankruptcy court permission on Wednesday to cancel the company’s sponsorship agreement with the Los Angeles theater where the Oscars have been held for the last 10… [read post]
16 Feb 2012, 6:00 am by SECLaw Staff
A former employee of Takeda Pharmaceuticals International, Inc. has been charged after trading on inside information about the Japanese firm’s business alliances and corporate acquisitions. [read post]
9 Feb 2012, 12:50 pm by Securites Lawprof
The SEC charged a former employee of Takeda Pharmaceuticals International, Inc. with trading on inside information about the Japanese firm’s business alliances and corporate acquisitions. [read post]
17 Sep 2011, 5:43 am by Jonathan Rosenfeld
The lawsuit alleges that Actos' manufacturer, Takeda Pharmaceuticals North America (and other entities including: Takeda Global Research & Development Center Inc., Takeda Pharmaceuticals Company Ltd., Takeda Pharmaceuticals America, Takeda San Diego Inc., Takeda Pharmaceuticals International Inc and Eli Lilly and Company), was negligent for not providing any warnings… [read post]